Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2024)
Top medical stocks in 2024 ranked by overall Zen Score. See the best medical stocks to buy now, according to analyst forecasts for the medical instruments & supplies industry.

Industry: Medical Instruments & Sup...

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
WST	WEST PHARMACEUTICAL SERVICES INC	United States	$24.35B	72,843,157	92.60%	3.69%	Net Buying	Net Buying
UTMD	UTAH MEDICAL PRODUCTS INC	United States	$237.50M	3,528,426	64.42%	35.58%	Net Selling	Net Selling
STAA	STAAR SURGICAL CO	United States	$2.09B	49,131,110	61.27%	38.73%	Net Buying	Net Selling
LMAT	LEMAITRE VASCULAR INC	United States	$1.80B	22,446,109	74.72%	25.28%	Net Selling	Net Selling
HOLX	HOLOGIC INC	United States	$17.46B	233,376,948	86.51%	13.49%	Net Selling	Net Selling
ISRG	INTUITIVE SURGICAL INC	United States	$142.20B	354,705,822	83.13%	0.81%	Net Buying	Net Selling
ALC	ALCON INC	United States	$44.87B	494,400,000	47.39%	0.00%
MMSI	MERIT MEDICAL SYSTEMS INC	United States	$4.77B	58,105,654	95.00%	5.00%	Net Buying	Net Selling
BDX	BECTON DICKINSON & CO	United States	$67.76B	289,006,461	84.33%	0.63%	Net Selling	Net Selling
RMD	RESMED INC	United States	$32.07B	146,907,207	55.27%	4.26%	Net Selling	Net Selling
OSUR	ORASURE TECHNOLOGIES INC	United States	$373.49M	73,959,289	91.54%	8.46%	Net Selling	Net Selling
ATRC	ATRICURE INC	United States	$1.10B	48,382,325	76.01%	23.99%	Net Selling	Net Selling
ATR	APTARGROUP INC	United States	$9.86B	66,263,631	88.13%	3.66%	Net Selling	Net Selling
ATRI	ATRION CORP	United States	$830.68M	1,759,954	58.60%	41.40%	Net Buying	Net Selling
NEPH	NEPHROS INC	United States	$23.41M	10,544,139	5.53%	94.47%	Net Buying	Net Buying
TFX	TELEFLEX INC	United States	$10.04B	47,102,562	94.36%	2.72%	Net Selling	Net Selling
COO	COOPER COMPANIES INC	United States	$19.20B	198,756,284	93.46%	0.86%	Net Selling	Net Selling
HAE	HAEMONETICS CORP	United States	$4.58B	50,841,442	97.46%	2.54%	Net Buying	Net Selling
MHUA	MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD	China	$17.57M	23,940,000	1.90%	0.00%
RGEN	REPLIGEN CORP	United States	$9.23B	55,875,894	72.68%	27.32%	Net Selling	Net Selling
STVN	STEVANATO GROUP SPA	Italy	$5.73B	295,540,036	17.31%	0.00%
BAX	BAXTER INTERNATIONAL INC	United States	$17.50B	509,580,190	84.51%	15.49%	Net Selling	Net Selling
NYXH	NYXOAH SA	Belgium	$290.27M	28,682,635	7.60%	0.00%
PDEX	PRO DEX INC	United States	$67.19M	3,419,089	5.97%	94.03%	Net Buying
AKYA	AKOYA BIOSCIENCES INC	United States	$112.85M	49,386,247	30.08%	51.98%	Net Buying	Net Selling
ZJYL	JIN MEDICAL INTERNATIONAL LTD	China	$457.60M	160,000,000	0.49%	0.00%
SMTI	SANARA MEDTECH INC	United States	$261.17M	8,625,201	0.53%	99.47%	Net Selling	Net Selling
EMBC	EMBECTA CORP	United States	$782.58M	57,670,209	95.86%	1.52%	Net Selling	Net Selling
FEMY	FEMASYS INC	United States	$28.89M	22,220,718	6.63%	8.01%
EKSO	EKSO BIONICS HOLDINGS INC	United States	$24.90M	18,174,426	5.61%	94.39%	Net Selling
WRBY	WARBY PARKER INC	United States	$2.00B	118,862,327	48.80%	51.20%	Net Selling	Net Selling
BLFS	BIOLIFE SOLUTIONS INC	United States	$1.01B	46,030,886	58.36%	41.64%	Net Buying	Net Selling
XRAY	DENTSPLY SIRONA INC	United States	$5.82B	207,630,556	97.77%	2.23%	Net Selling	Net Selling
OMIC	SINGULAR GENOMICS SYSTEMS INC	United States	$28.53M	74,092,970	34.26%	38.21%	Net Selling
BNGO	BIONANO GENOMICS INC	United States	$74.21M	66,856,804	7.34%	38.63%	Net Buying
LUCY	INNOVATIVE EYEWEAR INC	United States	$3.33M	17,501,066	1.02%	28.12%
HBIO	HARVARD BIOSCIENCE INC	United States	$143.32M	43,429,626	51.02%	48.98%	Net Selling	Net Selling
NXGL	NEXGEL INC	United States	$14.51M	6,227,624	2.42%	31.25%	Net Buying	Net Buying
KRMD	KORU MEDICAL SYSTEMS INC	United States	$102.05M	45,764,225	40.98%	49.24%	Net Buying	Net Buying
MLSS	MILESTONE SCIENTIFIC INC	United States	$59.62M	77,227,714	5.39%	57.13%	Net Buying	Net Buying
AZTA	AZENTA INC	United States	$2.75B	53,918,934	81.75%	18.25%	Net Selling	Net Selling
MBOT	MICROBOT MEDICAL INC	United States	$15.55M	14,398,964	4.35%	95.65%
POAI	PREDICTIVE ONCOLOGY INC	United States	$6.69M	4,101,776	0.16%	99.84%	Net Selling
BLCO	BAUSCH & LOMB CORP	Canada	$5.17B	351,482,100	9.34%	88.95%	Net Selling	Net Selling
INFU	INFUSYSTEM HOLDINGS INC	United States	$152.47M	21,295,254	26.51%	73.49%	Net Selling	Net Selling
ICUI	ICU MEDICAL INC	United States	$2.57B	24,365,990	69.05%	30.95%	Net Selling	Net Selling
POCI	PRECISION OPTICS CORPORATION INC	United States	$40.11M	6,068,518	9.37%	90.63%
AVGR	AVINGER INC	United States	$5.02M	1,702,226	1.21%	98.79%	Net Selling
STXS	STEREOTAXIS INC	United States	$172.72M	82,643,243	27.37%	72.63%	Net Buying
PLSE	PULSE BIOSCIENCES INC	United States	$659.39M	55,225,333	8.61%	78.43%	Net Buying	Net Buying
RVP	RETRACTABLE TECHNOLOGIES INC	United States	$27.45M	29,937,159	6.54%	93.46%	Net Buying	Net Buying
NVST	ENVISTA HOLDINGS CORP	United States	$3.20B	171,858,245	62.86%	37.14%	Net Selling	Net Selling
GCTK	GLUCOTRACK INC	United States	$11.83M	5,478,600	14.32%	61.42%	Net Buying	Net Buying
ZTEK	ZENTEK LTD	Canada	$112.05M	100,859,577	0.93%	0.00%
STSS	SHARPS TECHNOLOGY INC	United States	$3.96M	15,670,898	7.40%	23.64%	Net Buying
ANGO	ANGIODYNAMICS INC	United States	$253.14M	40,054,533	79.66%	20.34%	Net Selling	Net Buying

Medical Stocks FAQ

What are the best medical stocks to buy right now in May 2024?

According to Zen Score, the 3 best medical stocks to buy right now are:

1. West Pharmaceutical Services (NYSE:WST)

West Pharmaceutical Services (NYSE:WST) is the top medical stock with a Zen Score of 56, which is 28 points higher than the medical industry average of 28. It passed 21 out of 38 due diligence checks and has strong fundamentals. West Pharmaceutical Services has seen its stock lose -4.74% over the past year, overperforming other medical stocks by 3 percentage points.

West Pharmaceutical Services has an average 1 year price target of $460.33, an upside of 37.7% from West Pharmaceutical Services's current stock price of $334.29.

West Pharmaceutical Services stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering West Pharmaceutical Services, 66.67% have issued a Strong Buy rating, 0% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Utah Medical Products (NASDAQ:UTMD)

Utah Medical Products (NASDAQ:UTMD) is the second best medical stock with a Zen Score of 50, which is 22 points higher than the medical industry average of 28. It passed 17 out of 38 due diligence checks and has strong fundamentals. Utah Medical Products has seen its stock lose -28.23% over the past year, underperforming other medical stocks by -21 percentage points.

3. Staar Surgical Co (NASDAQ:STAA)

Staar Surgical Co (NASDAQ:STAA) is the third best medical stock with a Zen Score of 49, which is 21 points higher than the medical industry average of 28. It passed 16 out of 33 due diligence checks and has strong fundamentals. Staar Surgical Co has seen its stock lose -33.96% over the past year, underperforming other medical stocks by -27 percentage points.

Staar Surgical Co has an average 1 year price target of $44.60, an upside of 4.82% from Staar Surgical Co's current stock price of $42.55.

Staar Surgical Co stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Staar Surgical Co, 40% have issued a Strong Buy rating, 0% have issued a Buy, 60% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the medical stocks with highest dividends?

Out of 11 medical stocks that have issued dividends in the past year, the 3 medical stocks with the highest dividend yields are:

1. Baxter International (NYSE:BAX)

Baxter International (NYSE:BAX) has an annual dividend yield of 3.38%, which is 2 percentage points higher than the medical industry average of 1.28%. Baxter International's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Baxter International's dividend has not shown consistent growth over the last 10 years.

Baxter International's dividend payout ratio of 22.2% indicates that its dividend yield is sustainable for the long-term.

2. Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 2.07%, which is 1 percentage points higher than the medical industry average of 1.28%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -134.9% indicates that its dividend yield might not be sustainable for the long-term.

3. Atrion (NASDAQ:ATRI)

Atrion (NASDAQ:ATRI) has an annual dividend yield of 1.85%, which is 1 percentage points higher than the medical industry average of 1.28%. Atrion's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Atrion's dividend has shown consistent growth over the last 10 years.

Atrion's dividend payout ratio of 82.3% indicates that its dividend yield is sustainable for the long-term.

Why are medical stocks up?

Medical stocks were up 0.58% in the last day, and down -2.19% over the last week.

We couldn't find a catalyst for why medical stocks are up.

What are the most undervalued medical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued medical stocks right now are:

1. Utah Medical Products (NASDAQ:UTMD)

Utah Medical Products (NASDAQ:UTMD) is the most undervalued medical stock based on WallStreetZen's Valuation Score. Utah Medical Products has a valuation score of 71, which is 52 points higher than the medical industry average of 19. It passed 5 out of 7 valuation due diligence checks.

Utah Medical Products's stock has dropped -28.23% in the past year. It has underperformed other stocks in the medical industry by -21 percentage points.

2. Hologic (NASDAQ:HOLX)

Hologic (NASDAQ:HOLX) is the second most undervalued medical stock based on WallStreetZen's Valuation Score. Hologic has a valuation score of 71, which is 52 points higher than the medical industry average of 19. It passed 5 out of 7 valuation due diligence checks.

Hologic's stock has dropped -8.35% in the past year. It has underperformed other stocks in the medical industry by -1 percentage points.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the third most undervalued medical stock based on WallStreetZen's Valuation Score. Embecta has a valuation score of 57, which is 38 points higher than the medical industry average of 19. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -49.46% in the past year. It has underperformed other stocks in the medical industry by -42 percentage points.

Are medical stocks a good buy now?

47.5% of medical stocks rated by analysts are a strong buy right now. On average, analysts expect medical stocks to rise by 19.78% over the next year.

What is the average p/e ratio of the medical instruments & supplies industry?

The average P/E ratio of the medical instruments & supplies industry is 58.84x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.